HOU Fenghui, DUAN Lizhi, YU Li, WU Huimin. Expression of serum lipoprotein and high sensitivity C-reactive protein in serum of patients with type 2 diabetic nephropathy and its clinical significance[J]. Journal of Clinical Medicine in Practice, 2014, (17): 33-35. DOI: 10.7619/jcmp.201417010
Citation: HOU Fenghui, DUAN Lizhi, YU Li, WU Huimin. Expression of serum lipoprotein and high sensitivity C-reactive protein in serum of patients with type 2 diabetic nephropathy and its clinical significance[J]. Journal of Clinical Medicine in Practice, 2014, (17): 33-35. DOI: 10.7619/jcmp.201417010

Expression of serum lipoprotein and high sensitivity C-reactive protein in serum of patients with type 2 diabetic nephropathy and its clinical significance

More Information
  • Published Date: October 16, 2014
  • Obj ective To explore the significance of serum lipoprotein and high sensitivity C-reactive protein (hs-CRP)level for the patients with type 2 diabetic nephropathy.Methods 174 patients with type 2 diabetic mellitus were divided into diabetic mellitus group,early diabetic nephropathy group and clinical diabetic nephropathy group,according to the urinary albumin excre-tion rate (UAER).60 healthy individuals were chosen as control group.Lipoprotein (α)[Lp(α)], high density lipoprotein cholesterol (HDL-C),low density lipoprotein cholesterol (LDL-C)and hs-CRP were detected,and the results were analyzed statistically.Results The level of Lp (α), hs-CRP were significantly higher in patients with diabetic mellitus than those in control group (P<0.05).Among the three groups with diabetic mellitus,the level of Lp(α)and hs-CRP got progres-sively significant higher with the increase of UAER (P<0 .05 )whereas the level of HDL-C and LDL-C did not find significant difference(P>0 .05 ).There were linear positive correlation between Lp(α),hs-CRP and UAER levels(r= 0.8069,0.8989).Conclusion Lp(α),hs-CRP levels may be related to the progression of diabetic nephropathy,and their detection had important clinical sig-nificance in early diagnosis and prognostic evaluation of type 2 diabetic nephropathy.
  • Shide K, Takada Y, Nakashima A. Patients′Percep-tion on the Nutritional Therapy for Diabetic Nephropathy [J]. Japanese clinical medicine, 2014.9.
    Choudhary N, Ahlawat R S. Interleukin-6 and C-reactive protein in pathogenesis of diabetic nephropathy:new evidence linking inflammation, glycemic control, and microalbuminuria [J]. Iranian journal of kidney diseases, 2008(2):72.
    Nath I, Nath C K, Baruah M. A Study of Inflamma-tory Status in Nephropathy Patients with History of Type-II Diabetes Mel itus Undergoing Haemodialysis [J]. J Clin Diagn Res, 2013, (10):2143.
    Del Caizo Gó mez F J, Ferná ndez Pé rez C, Moreno Ruiz I. Microvascular complications and risk factors in patients with type 2 diabetes [J]. Endocrinología y Nutrición, 2011(4):163.
    Shelbaya S, Amer H, Seddik S. Study of the role of interleukin-6 and highly sensitive C-reactive protein in diabet-ic nephropathy in type 1 diabetic patients [J]. European Review for Medical and Pharmacological Science, 2012(2):176.
    Fu C C, Wu D A, Wang J. Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chi-nese type 2 diabetic patients [J]. ACTA DIABETOLOGICA, 2009(2):127.
    Chandni R, Ramamoorthy K P. Lipoprotein (a)in type 2 di-abetic subj ects and its relationship to diabetic microvascular complications [J]. World journal of diabetes, 2012(5):105.
    林浩, 熊石龙. 2型糖尿病肾病患者血清脂蛋白(a)和超敏C反应蛋白的变化及其相关性分析 [J]. 中南医学科学杂志, 2013(4):375.
    Wan Z M, Chen W Y, Lu M L. Higher procalcitonin level in diabetic nephropathy patients compared with healthy volunteers [J]. Journal of Sichuan University, 2014(3):442.
    贾利敏. 糖尿病肾病患者脂蛋白a变化的研究 [J]. 现代中西医结合杂志, 2014(7):769.doi: 10.3969/j.issn.1008-8849.2014.07.040.

Catalog

    Article views (195) PDF downloads (0) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return